Trillions of microorganisms play a pivotal role in maintaining health and preventing disease in humans. Their presence influences daily life, habits, energy levels, and pathologies. The present narrative review synthesized recent studies of microbial diversity across organ systems. The composition of the microbiota regulates the intestinal barrier, modulates the immune response, influences metabolism, and produces essential compounds such as short-chain fatty acids and neurotransmitters. Dysbiosis is associated with numerous pathologies, including metabolic, autoimmune, neurodegenerative, and cardiovascular diseases. The microbiota is key to maintaining physiological balance and reducing disease risk. Therapeutic interventions, such as probiotics, prebiotics, postbiotics, and microbiome transplantation, offer promising perspectives in restoring microbial homeostasis and preventing chronic diseases.

Background: Spinal anesthesia is considered the method of choice for elective cesarean sections; however, it is not without maternal–fetal risks. Materials and Methods: This study compared the effects on maternal hemodynamics of intrathecal administration of fentanyl or morphine in parturients undergoing spinal anesthesia with 0.5% hyperbaric bupivacaine, with doses varied between 7.5 and 11 mg, depending on the patient’s height. Data from a cohort of 170 parturients were analyzed. The administered doses were intrathecal morphine at 0.1 mL (100 µg, solution of 1 mg/mL) or fentanyl at 0.25 mL (25 µg, solution of 50 µg/mL). This study included 80 patients in the fentanyl (F) group and 90 in the morphine (M) group. Results: Group F showed significantly higher post-intervention systolic blood pressure values than group M (95.30 ± 12.99 mmHg vs. 90.58 ± 14.75 mmHg, p = 0.032). The incidence of vomiting was significantly less frequent in group F compared to group M (1, 1.3% vs. 10, 11.1%, p = 0.011). The total dose of ephedrine required for hypotension correction was significantly lower in the F group (12.75 ± 13.26 mg vs. 17.72 ± 16.73 mg, p = 0.035). Conclusions: The addition of fentanyl as an adjuvant alongside the local anesthetic in cesarean section is associated with enhanced hemodynamic stability compared to morphine, requiring lower doses of ephedrine and contributing to increased patient safety during elective cesarean surgery.

Intrathecal opioids (ITOs), such as morphine, fentanyl, and sufentanil, are widely used as adjuvants in spinal anesthesia for cesarean sections to enhance postoperative analgesia and reduce systemic opioid exposure. Optimizing their selection and dosing is critical to balancing effective analgesia with maternal and fetal safety. This article aims to critically analyze the use of intrathecal opioids in spinal anesthesia for cesarean sections, focusing on their mechanisms of action, clinical benefits, associated risks, and role within Enhanced Recovery After Surgery (ERAS) protocols. A comprehensive narrative review was conducted using PubMed, Scopus, and Google Scholar to identify relevant literature published between January 2010 and March 30, 2025. Morphine provides prolonged postoperative analgesia but is associated with higher rates of pruritus and delayed respiratory depression. Fentanyl and sufentanil offer faster onset but shorter analgesic duration. Combining intrathecal opioids with local anesthetics improves hemodynamic stability and reduces overall opioid requirements. While adverse effects are common, they are dose-dependent and manageable with appropriate monitoring. The tailored selection of intrathecal opioids, guided by pharmacological profiles and patient-specific factors, enhances analgesia and patient-specific safety in cesarean delivery. Refining dosing strategies and integrating multimodal analgesia protocols are essential to minimize adverse effects and optimize maternal and neonatal outcomes.

Background/Objectives: COVID-19 led to a pandemic that has brought misery to millions of people but more so to those with pre-existing conditions. For this infection, several antiviral drugs were employed, including remdesivir (R) and Paxlovid (nirmatrelvir/ritonavir (NR)). Methods: The current study compared the effectiveness of remdesivir and Paxlovid treatment for COVID-19 patients with comorbid conditions. Data from a cohort of 151 adult patients with COVID-19 who also had associated comorbidities were used in this study. These patients were treated with antivirals according to local guidelines. The subjects included 78 case-patients assigned to group R and 73 to group NR. Results: In group NR, a considerable improvement in oxygen saturation was seen in the first 24 h of treatment (p = 0.010), but the levels were significantly higher from the second day of treatment (p < 0.001) in group R of patients. At the end of the 5 days of treatment, the oxygen saturation improved statistically significantly compared to the admission day, but only in the R group (95.11 ± 1.80; 91.76 ± 1.80; p < 0.001). Conclusions: Both drugs can be considered a breakthrough in the current treatment approach to the COVID-19 disease since they provide readily available options that can alleviate the severity of the disease and, hence, the prognosis of patients. That is why their effectiveness relies on the correct administration time and choosing the patient with suitable characteristics regarding the presence of comorbidities and the likelihood of the critical further development of the process.

During the COVID-19 pandemic, a significant increase in cases of mucormycosis was observed in COVID-19 patients, especially in India, but not exclusively. The presented cases highlight the heterogeneous nature of mucormycosis, emphasizing the importance of recognizing predisposing factors, such as immunosuppression, due to comorbidities or medication. Diagnosing mucormycosis poses a challenge due to nonspecific clinical manifestations, requiring a multidisciplinary approach for accurate diagnosis. Treatment involves a multi-pronged approach centered around the early initiation of antifungal therapy alongside surgical intervention and the management of underlying conditions, with an emphasis on controlling immunosuppression. Understanding the relationship between COVID-19 and predisposing factors for mucormycosis is fundamental for developing prevention and treatment strategies.

Background/Objectives: The gut–liver axis is bidirectional and influences the body’s homeostasis. Pathologies such as metabolic dysfunction-associated steatotic liver (MASL) can have detrimental effects on the human microbiome, with multiple systemic effects. Furthermore, the geographical particularities of the intestinal microbiome may influence liver disease. The study’s outcome was to identify dysbiosis in a group of patients with MASL from the western region of Romania. Methods: The NGS shotgun genomic sequencing (WGS metagenomics) method was used to identify bacteria in fecal samples. The data were analyzed using IBM SPSS Statistics software [version 29.0.2.0 (20)]. Results: Out of the 122 MASL patients included in the study, 43 (35.24%) exhibited low alpha diversity. In the subgroup with a normal biodiversity index, approximately half were identified with a Firmicutes/Bacteroidetes ratio below the lower reference value, while the remaining patients presented dysbiosis based on decreased concentrations of Proteobacteria and Prevotella, considered among the most relevant species supporting dysbiosis. A higher prevalence of Prevotella species (15.99 ± 13.65%) was identified in the study cohort. Conclusions: The present study demonstrates that patients with MASL from the western region of Romania exhibit criteria for intestinal dysbiosis, namely reduced bacterial diversity, along with significant alterations in populations of Firmicutes, Bacteroidetes, Proteobacteria, and Prevotella. Together, these findings suggest a possible influence of geo-cultural factors on the intestinal microbiome, highlighting the need for regionally adapted therapeutic interventions to support liver health.